Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

In the middle of the TV is an upside-down pink triangle crossed out by a red "no" symbol. The pink triangle was used as a badge to identify gay men in concentration camps, and many received ...

According to Reuters, the expanded partnership now enables Reddit (RDDT) to use Google’s Vertex AI, an AI development platform by Google Cloud that enables its users to build, deploy and scale ...

This annual award recognizes young professionals who are shaping Triangle business and their communities for the better. Triangle Business Journal on Thursday unveiled its 2025 class of 40 Under ...

It’s all in the eyes. They say that eyes are a window into your soul — but research shows they might also serve as an early window into cognitive decline. A study published in Neurology ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Russia has hit on an "offensive triangle" of tactics that are forcing Ukraine to lose ground. The key to reviving Russian airpower has been a surprisingly low-tech weapon: glide bombs. Glide bombs ...

Pakistan Prime Minister Muhammad Shehbaz Sharif (left) meets Chief Advisor of the Interim Government of Bangladesh Dr. Muhammad Yunus on the sidelines of the United ...